ECE 2021

Endokrine Disruptoren

Hypoparathyreodismus neu bewertet

Cushing-Syndrom - aktuelle Therapielandschaft

Sequenztherapie der Osteoporose

Neue Entwicklungen bei AGS-Therapie

AAV liver gene therapy-mediated inhibition of FGF23 signaling as a therapeutic strategy for X-linked hypophosphatemia

Deficiency or insufficiency of vitamin D and the frequency of hypocalcemia episodes and the circadian rhythm of serum calcium level

Bisphosphonates after Denosumab withdrawal reduce the vertebral fractures incidence

Safety, tolerability and pharmacodynamics of AZP-3601, a novel long-acting PTH analog, in healthy adults: Data from a randomized, double-blind, placebo-controlled phase 1 study

One year in bone

News about hypophosphatasia

Bone consequences of high dose denosumab to treat an aneurysmal bone cyst, an example of the European Reference Network support

The effect of intra-operative autofluorescence monitoring on unintentional parathyroid gland excision rates and post-operative PTH concentrations

Non-nuclear cataracts in hypoparathyroidism are associated with biochemical control of the disease

Risk of chronic kidney disease and change in GFR in adult patients with chronic hypoparathyroidism treated with rhPTH(1–84) compared with a historical control cohort

Quantifying the real-world clinical and economic burden of chronic hypoparathyroidism on secondary care in England: A multi-arm, retrospective cohort study

TransCon PTH as a potential hormone replacement therapy for

patients with hypoparathyroidism: PaTH forward open-label

extension trial week 26 results

Cardiovascular events in adult patients with chronic hypoparathyroidism treated with rhPTH(1–84) compared with a historical control cohort

Challenges of hypoparathyroidism

Tildacerfont for the treatment of patients with classic congenital adrenal hyperplasia: results from a 12-week phase 2 clinical trial in adults with classic CAH

Steroid metabolomics for the detection of malignancy in adrenal tumours

Results of the ADIUVO trial, the first randomized study on post-operative adjuvant mitotane in patients with adrenocortical carcinoma

Novel treatment and monitoring options for CAH

Fascin-1, a novel-circulating marker for the prognosis of the metastatic adrenocortical carcinoma

Salivary steroid and 11‑oxygenated androgen profiles in patients with congenital adrenal hyperplasia on various glucocorticoid replacement regimens

Primary results from MATCH: A randomised controlled trial in primary aldosteronism

Adverse events of mitotane treatment in patients with adrenocortical carcinoma

Neuroendocrine stress response at single cell resolution

Pre-operative hypercortisolism and post-operative adrenal insufficiency in pheochromocytomas: a single center retrospective analysis of 168 patients

Addition of cabergoline to oral octreotide capsules may improve biochemical control in patients with acromegaly who are inadequately controlled with monotherapy

A Phase 3 Large International Noninferiority Trial (MPOWERED): Assessing Maintenance of Response to Oral Octreotide Capsules in Comparison to Injectable Somatostatin Receptor Ligands

GH replacement in adults

Metyrapone treatment in endogenous Cushing’s syndrome. Long term efficacy and safety results of the extension of the phase III/IV study PROMPT

Reassessment of the diagnostic criteria of insulinoma: A retrospective monocentric cohort study of 72-h fasting trial in 124 patients

Osilodrostat, a potent oral 11β-hydroxylase inhibitor

Identification of a dose range for once daily oral paltusotine in patients with acromegaly that maintains IGF-1 levels when switching from long-acting somatostatin receptor ligand therapy

Thymic neuroendocrine tumor and mortality in MEN 1 patients: the spanish registry

Can the follow-up imaging interval for non-functioning pituitary microadenomas be extended?

Osilodrostat provides sustained control of urinary free cortisol in patients with Cushing’s disease: final results from a prospective, open-label study (LINC 2)

Non-contraceptive therapeutic use of combined oral contraceptives in PCOS

Effect of IL-1 receptor antagonism on hyperandrogenemia in women with polycystic ovary syndrome

Long-term effects of testosterone replacement therapy

Monogenic variants in the Finnish Pediatric Diabetes Register

Endocrine Disruptors - a key challenge for endocrinologists, authorities and our future

COVID-19 and hormones – the role of Endocrinologists in preventing and improving outcomes of COVID-19